1. Home
  2. MSW vs NUWE Comparison

MSW vs NUWE Comparison

Compare MSW & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSW
  • NUWE
  • Stock Information
  • Founded
  • MSW 2012
  • NUWE 1999
  • Country
  • MSW Hong Kong
  • NUWE United States
  • Employees
  • MSW N/A
  • NUWE N/A
  • Industry
  • MSW
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • MSW
  • NUWE Health Care
  • Exchange
  • MSW NYSE
  • NUWE Nasdaq
  • Market Cap
  • MSW N/A
  • NUWE 3.9M
  • IPO Year
  • MSW 2024
  • NUWE N/A
  • Fundamental
  • Price
  • MSW $3.87
  • NUWE $1.00
  • Analyst Decision
  • MSW
  • NUWE Strong Buy
  • Analyst Count
  • MSW 0
  • NUWE 1
  • Target Price
  • MSW N/A
  • NUWE $17.00
  • AVG Volume (30 Days)
  • MSW 63.1K
  • NUWE 70.5K
  • Earning Date
  • MSW 05-25-2025
  • NUWE 05-13-2025
  • Dividend Yield
  • MSW N/A
  • NUWE N/A
  • EPS Growth
  • MSW 18.78
  • NUWE N/A
  • EPS
  • MSW 0.20
  • NUWE N/A
  • Revenue
  • MSW $31,769,612.00
  • NUWE $8,740,000.00
  • Revenue This Year
  • MSW N/A
  • NUWE $22.96
  • Revenue Next Year
  • MSW N/A
  • NUWE $29.97
  • P/E Ratio
  • MSW $18.45
  • NUWE N/A
  • Revenue Growth
  • MSW 30.91
  • NUWE N/A
  • 52 Week Low
  • MSW $2.12
  • NUWE $0.75
  • 52 Week High
  • MSW $10.58
  • NUWE $12.60
  • Technical
  • Relative Strength Index (RSI)
  • MSW N/A
  • NUWE 52.93
  • Support Level
  • MSW N/A
  • NUWE $0.87
  • Resistance Level
  • MSW N/A
  • NUWE $1.06
  • Average True Range (ATR)
  • MSW 0.00
  • NUWE 0.09
  • MACD
  • MSW 0.00
  • NUWE 0.02
  • Stochastic Oscillator
  • MSW 0.00
  • NUWE 79.31

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: